Suppr超能文献

小细胞肺癌的现代分期。

Modern staging of small cell lung cancer.

机构信息

Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109-5848, USA.

出版信息

J Natl Compr Canc Netw. 2013 Jan 1;11(1):99-104. doi: 10.6004/jnccn.2013.0012.

Abstract

For many years, small cell lung cancer (SCLC) has been staged using the Veterans Affairs classification system, which includes only 2 stages: limited (primary tumor and regional lymph nodes within a tolerable radiation field) and extensive (anything beyond limited stage). The TNM staging system used for non-small cell lung cancer is also prognostic for SCLC and should be integrated into the classification scheme for patients with SCLC. The staging workup for SCLC has traditionally included contrast-enhanced CT scans of the chest and abdomen, bone scan, and MRI or CT scan of the brain. Recent data suggest that PET can improve both staging accuracy and treatment planning in patients with SCLC, although further prospective studies are needed to fully define its role.

摘要

多年来,小细胞肺癌 (SCLC) 一直采用退伍军人事务分类系统进行分期,该系统仅包括 2 个分期:局限期(原发性肿瘤和可耐受放疗区域内的局部淋巴结)和广泛期(超出局限期的任何范围)。用于非小细胞肺癌的 TNM 分期系统也可预测 SCLC 的预后,应将其纳入 SCLC 患者的分类方案中。SCLC 的分期检查传统上包括胸部和腹部增强 CT 扫描、骨扫描,以及脑 MRI 或 CT 扫描。最近的数据表明,PET 可以提高 SCLC 患者的分期准确性和治疗计划制定,尽管还需要进一步的前瞻性研究来充分确定其作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验